Verrica Pharmaceuticals Inc. Accrued Liabilities, Current
Verrica Pharmaceuticals Inc. (VRCA) had Accrued Liabilities, Current of $2.04 million as of 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2020-03-13
- 2019-12-31: Accrued Liabilities, Current $2.04M.
- 2019-09-30: Accrued Liabilities, Current $3.19M.
- 2019-06-30: Accrued Liabilities, Current $2.68M.
- 2019-03-31: Accrued Liabilities, Current $1.80M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2019-12-31 | $2.04M 10-K · filed 2020-03-13 |
| 2019-09-30 | $3.19M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.68M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.80M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.52M 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.35M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.01M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $449.00K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |